Education
About Us
Working with TipRanks
Follow Us
Moolec Science (MLEC)
NASDAQ:MLEC
Earnings Data
Report Date
May 28, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: -13.94%
|Next Earnings Date:May 28, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with significant achievements in revenue growth, regulatory approvals, and strategic partnerships. However, there are challenges with increased operating expenses and cash utilization.Company Guidance
During Moolec Science's fourth quarter and full fiscal year 2024 conference call, the company shared key financial metrics and future guidance. The fiscal year 2024 saw a significant increase in normalized revenues, jumping from approximately $1 million in 2023 to $5.8 million in 2024, largely due to the consolidation of the soy product ingredient business. The cost of sales increased correspondingly, from close to $1 million in 2023 to $4.5 million in 2024, resulting in an annual gross margin that remains undisclosed. Expenses, including SG&A and R&D, rose by $3.1 million, reaching $9.3 million, driven by non-cash items and the soy ingredient business consolidation. Cash utilization in operating activities increased from $7.5 million in 2023 to $9.3 million in 2024, with a significant $4 million reduction in accounts payable. As of Q4 2024, the cash position stood at approximately $5.4 million, bolstered by the strategic purchase of 15,000 tons of HB4 soybean. Looking ahead, Moolec anticipates fiscal year 2025 to be pivotal, with the commercialization of new science-based ingredients like Glaso, supported by a three-year contract with a major CPG company, and efforts to enhance operational efficiencies and regulatory progress.Significant Revenue Increase
Normalized revenues increased from approximately $1 million in 2023 to $5.8 million in 2024, due to the consolidation of the soy product ingredient business.
Regulatory Approval Breakthrough
Moolec received the first-ever USDA approval for Piggy Sooy, making it the first company in the industry to achieve such a regulatory milestone.
Successful R&D and Commercialization Efforts
Moolec has successfully set up a fully owned plant molecule and biology lab, achieved significant results in transgenic events, and is preparing for the commercialization of Glaso products.
Strategic Partnerships and Growth Plans
Moolec signed an offtake agreement with a major global CPG company for Glaso and an R&D collaboration with Bunge to develop safflower varieties.
MLEC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MLEC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 28, 2025 | $8.25 | $7.80 | -5.45% |
Mar 12, 2025 | $9.40 | $8.56 | -8.94% |
Dec 12, 2024 | $9.20 | $8.40 | -8.70% |
Oct 02, 2024 | $8.50 | $9.00 | +5.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Moolec Science (MLEC) report earnings?
Moolec Science (MLEC) is schdueled to report earning on May 28, 2025, TBA Not Confirmed.
What is Moolec Science (MLEC) earnings time?
Moolec Science (MLEC) earnings time is at May 28, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MLEC EPS forecast?
Currently, no data Available